Kinexus is a privately-held biotechnology company that was incorporated on July 30, 1999. In the Spring of 2000, Kinexus completed a $1.1 million private seed financing that was made by a syndicate of private and institutional investors, lead by Toronto-based Milestone Medical Corporation, Vancouver-based venture capital firm BIRC Capital Corporation, Sanovest, and FutureFund Capital (VCC) Corporation (acquired by Pender Growth Fund).
In 2001, Kinexus added to this financing a second tranche investment of $1.0 million by Milestone Medica Corporation, Bio-FutureFund (acquired by Pender Growth Fund), Sanovest and BIRC Corporation that was triggered by completion of all the development milestones that were set in Spring 2000. In April 2002, Kinexus raised an additional $1.25 million in private financing. In June 2006, Mickeric Enterprises acquired the Kinexus shares held by Milestone Medical Corporation and Pender Growth Fund. In February 2010, Dr. Pelech acquired the Kinexus shares held by BIRC Corporation.